↓ Skip to main content

Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study

Overview of attention for article published in BMC Psychiatry, October 2013
Altmetric Badge

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study
Published in
BMC Psychiatry, October 2013
DOI 10.1186/1471-244x-13-244
Pubmed ID
Authors

Rani Samuel, Azizah Attard, Marinos Kyriakopoulos

Abstract

The appropriateness of use of generic instead of brand-name medication remains unresolved and controversial in several areas of medicine. Some evidence suggestive of variations in bioavailability and clinical effectiveness between different formulations make policy decisions occasionally difficult. The use of generic olanzapine is a widely acceptable practice on the basis of quality, safety and efficacy data and has been adopted in several countries.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 21%
Student > Bachelor 10 15%
Researcher 8 12%
Student > Doctoral Student 6 9%
Student > Ph. D. Student 5 8%
Other 11 17%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 16 24%
Psychology 13 20%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Agricultural and Biological Sciences 3 5%
Social Sciences 3 5%
Other 12 18%
Unknown 15 23%